STOCK TITAN
  1. Home
  2. Sec-filings
  3. RADX
  4. [6-K] Radiopharm Theranostics Ltd Current Report (Foreign Issuer)

Radiopharm Theranostics Limited (RADX) issues 408.8M shares at A$0.015

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Radiopharm Theranostics Limited reported ASX quotation of 408,839,531 RAD ordinary fully paid shares, issued for cash at AUD 0.015 per share, as part of a placement previously outlined in an Appendix 3B dated 24 July 2026.

Following this quotation, RAD ordinary shares on issue total 4,337,549,491. The company also describes further securities yet to be issued to complete the transaction, including 40,000,000 additional RAD ordinary shares, 448,839,531 options expiring 31 July 2029 with a 0.018 exercise price, and ADR warrants expiring 31 July 2029 with exercise prices of USD 3.95 and USD 3.79.

Positive

  • None.

Negative

  • None.
New RAD shares quoted 408,839,531 shares RAD ordinary fully paid shares to be quoted on ASX with issue date 03/08/2026
Issue price per share AUD 0.01500000 Cash consideration per RAD ordinary fully paid share
Total RAD shares on issue 4,337,549,491 shares RAD ordinary fully paid shares on issue after quotation of new securities
Further RAD shares to be issued 40,000,000 shares Additional RAD ordinary fully paid shares yet to be issued under Appendix 3B transaction
Options yet to be issued 448,839,531 options New class options expiring 31-JUL-2029 with 0.018 exercise price
ADR warrants EX USD 3.95 64,082 warrants New class ADR WARRANTS expiring 31-JUL-2029 with USD 3.95 exercise price
ADR warrants EX USD 3.79 1,281,646 warrants New class ADR WARRANTS expiring 31-JUL-2029 with USD 3.79 exercise price
+securities regulatory
"The +securities to be quoted are +Securities issued as part of a transaction"
Application for quotation of securities regulatory
"Exhibit 99.1 | Application for quotation of securities - RAD"
Appendix 3B regulatory
"previously announced to the market in an Appendix 3B"
ADR WARRANTS financial
"New class ADR WARRANTS EXPIRING 31-JUL-2029 EX USD 3.95"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 6-K: How Foreign Companies Report to the SEC →

FAQ

What new securities did THERANOSTICS LIMITED (RADX) obtain quotation for in August 2026?
THERANOSTICS LIMITED obtained ASX quotation for 408,839,531 RAD ordinary fully paid shares, issued for cash at AUD 0.015 per share, with an issue date of 03/08/2026 under a placement previously described in an Appendix 3B lodged on 24 July 2026.

What was the issue price for the new RAD ordinary shares issued by THERANOSTICS LIMITED (RADX)?
The new RAD ordinary fully paid shares were issued for cash at an issue price of AUD 0.015 per share, with the cash consideration denominated in AUD – Australian Dollar, as stated in the Application for quotation of securities for Radiopharm Theranostics Limited.

How many RAD ordinary shares will be on issue for THERANOSTICS LIMITED (RADX) after this quotation?
After quotation of the new shares, total RAD ordinary fully paid shares on issue for Radiopharm Theranostics Limited will be 4,337,549,491. This figure represents the company’s quoted ordinary share capital on ASX following inclusion of the 408,839,531 newly issued shares.

What additional securities are yet to be issued under the previously announced placement for THERANOSTICS LIMITED (RADX)?
To complete the Appendix 3B transaction, the company details further securities yet to be issued: 40,000,000 RAD ordinary shares, 448,839,531 options expiring 31 July 2029 with a 0.018 exercise price, plus 64,082 and 1,281,646 ADR warrants with exercise prices of USD 3.95 and USD 3.79, respectively.

What existing options of THERANOSTICS LIMITED (RADX) are quoted following this share issue?
Following this quotation, existing quoted options include 79,352,040 RADO options expiring 30-Nov-2026, 818,890,534 RADOA options expiring 24-Aug-2026, and 1,179,266,658 RADOB options expiring 31-Oct-2027, along with several other option series with various expiry dates and exercise prices.

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

 

For the Month of August 2026

 

Commission File Number: 001-41621

 

RADIOPHARM THERANOSTICS LIMITED

(Name of Registrant)

 

Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒       Form 40-F ☐

 

 

 

 

 

 

RADIOPHARM THERANOSTICS LIMITED

 

EXPLANATORY NOTE

 

Radiopharm Theranostics Limited (the “Company”) published one announcement (the “Public Notice”) to the Australian Securities Exchange on August 03, 2026 titled:

 

  “Application for quotation of securities - RAD

 

A copy of the Public Notice is attached as an exhibit to this report on Form 6-K.

 

This report on Form 6-K (including any exhibit hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934 and shall not be incorporated by reference into any registration statement or prospectus under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such registration statement or prospectus.

 

1

 

 

EXHIBITS

 

Exhibit
Number		   Description
99.1   Application for quotation of securities - RAD

 

2

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  RADIOPHARM THERANOSTICS LIMITED
     
Date: August 03, 2026 By: /s/ Amritha Sushil
    Amritha Sushil
    Company Secretary

 

3

 

Exhibit 99.1

 

  Appendix 2A - Application for quotation of securities

 

Announcement Summary

 

 

 

Entity name

 

RADIOPHARM THERANOSTICS LIMITED

 

Announcement Type

 

New announcement

 

Date of this announcement

 

Monday August 03, 2026

 

The +securities to be quoted are:

 

+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B

 

Total number of +securities to be quoted

 

ASX +security code Security description Number of +securities to be quoted Issue date
RAD ORDINARY FULLY PAID 408,839,531 03/08/2026

  

Refer to next page for full details of the announcement

 

Appendix 2A - Application for quotation of securities1/6

 

 

  Appendix 2A - Application for quotation of securities

 

Part 1 - Entity and announcement details

 

 

 

1.1Name of entity

 

RADIOPHARM THERANOSTICS LIMITED

 

We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.

 

1.2Registered Number Type Registration Number
     
 ACN 647877889

 

1.3ASX issuer code

 

RAD

 

1.4The announcement is

 

New announcement

 

1.5Date of this announcement

 

3/8/2026

 

Appendix 2A - Application for quotation of securities2/6

 

 

  Appendix 2A - Application for quotation of securities

 

Part 2 - Type of Issue

 

 

 

2.1The +securities to be quoted are:

 

+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B

 

Previous Appendix 3B details: 

 

  Announcement Date and Time   Announcement Title   Selected Appendix 3B to submit quotation request
           
  24-Jul-2026 17:21   New - Proposed issue of securities - RAD   A placement or other type of issue

 

2.3a.2 Are there any further issues of +securities yet to take place to complete the transaction(s) referred to in the Appendix 3B?

 

Yes

 

2.3a.3 Please provide details of the further issues of +securities yet to take place to complete the transaction(s) referred to in the Appendix 3B

 

  40,000,000 RAD ORDINARY FULLY PAID
  448,839,531 New class OPTION EXPIRING 31-JUL-2029 EX 0.018
  64,082 New class ADR WARRANTS EXPIRING 31-JUL-2029 EX USD 3.95
  1,281,646 New class ADR WARRANTS EXPIRING 31-JUL-2029 EX USD 3.79

  

Appendix 2A - Application for quotation of securities3/6

 

 

  Appendix 2A - Application for quotation of securities

 

Part 3A - number and type of +securities to be quoted where issue has previously been notified to ASX in an Appendix 3B

 

 

 

Placement Details

 

 

 

ASX +security code and description

 

RAD : ORDINARY FULLY PAID

 

Issue date

 

3/8/2026

 

Distribution Schedule

 

 

 

Provide a distribution schedule for the new +securities according to the categories set out in the left hand column - including the number of recipients and the total percentage of the new +securities held by the recipients in each category.

 

Number of +securities held   Number of holders   Total percentage of +securities held
For example, to enter a value of 50% please input as 50.00
1 - 1,000       %
1,001 - 5,000       %
5,001 - 10,000       %
10,001 - 100,000       %
100,001 and over       %

 

Appendix 2A - Application for quotation of securities4/6

 

 

  Appendix 2A - Application for quotation of securities

 

Issue details

 

 

 

Number of +securities to be quoted

 

408,839,531

 

Are the +securities being issued for a cash consideration?

 

Yes

 

  In what currency is the cash consideration being paid?   What is the issue price per +security?
       
  AUD - Australian Dollar   AUD 0.01500000

 

Any other information the entity wishes to provide about the +securities to be quoted

 

 Per placement announcement dated 24 July 2026, 408,839,531 shares being issued as part of Tranche 1 of the Australian Placement.

 

Appendix 2A - Application for quotation of securities5/6

 

 

  Appendix 2A - Application for quotation of securities

 

Part 4 - Issued capital following quotation

 

 

 

Following the quotation of the +securities the subject of this application, the issued capital of the entity will comprise:

 

The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity’s current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.

 

4.1 Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the +securities subject of this application)

 

ASX +security code and description  Total number of
+securities on issue		 
     
RADO : OPTION EXPIRING 30-NOV-2026   79,352,040 
      
RAD : ORDINARY FULLY PAID   4,337,549,491 
      
RADOA : OPTION EXPIRING 24-AUG-2026   818,890,534 
      
RADOB : OPTION EXPIRING 31-OCT-2027   1,179,266,658 

 

4.2Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX)

 

ASX +security code and description  Total number of
+securities on issue		 
     
RADAK : OPTION EXPIRING 01-JUN-2027 EX $0.60   1,666,500 
      
RADAN : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES   387,179,525 
      
RADAJ : OPTION EXPIRING 01-JUL-2027 EX $0.17   12,425,675 
      
RADAF : OPTION EXPIRING 25-NOV-2026 RESTRICTED   8,666,678 
      
RADAG : OPTION EXPIRING 25-NOV-2026 EX $0.60   5,066,672 
      
RADAI : OPTION EXPIRING 27-MAY-2027 EX $0.60   740,000 
      
RADAP : OPTION EXPIRING 24-APR-2028 EX $0.09   8,955,224 

 

Appendix 2A - Application for quotation of securities6/6

 

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

1 document

Press Releases